Brain Scientific Inc. BRSF
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -35.64% | -449.05% | -- | -- | -- |
| Total Depreciation and Amortization | 275.25% | 2,025.20% | -- | -- | -- |
| Total Amortization of Deferred Charges | 2,974.16% | 167.84% | -- | -- | -- |
| Total Other Non-Cash Items | -15.02% | 599.36% | -- | -- | -- |
| Change in Net Operating Assets | 145.71% | -146.22% | -- | -- | -- |
| Cash from Operations | -1.17% | -155.92% | -- | -- | -- |
| Capital Expenditure | 43.17% | 30.42% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 200.00% | -- | -- | -- |
| Cash from Investing | 43.17% | 182.66% | -- | -- | -- |
| Total Debt Issued | -11.06% | 172.35% | -- | -- | -- |
| Total Debt Repaid | 14.47% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -10.76% | 140.19% | -- | -- | -- |
| Foreign Exchange rate Adjustments | 105.00% | -8,514.29% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -105.25% | 1,475.68% | -- | -- | -- |